2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis
Обновление рекомендаций Американской коллегии ревматологов 2008 года по применению базисных противоревматических препаратов и биологических средств для лечения ревматоидного артрита, 2012 год
2012-04-02
SCID: 54.1/2ebvxqvj
Discuss with AI
American College of Rheumatologybiologic agentsdisease-modifying antirheumatic drugsrheumatoid arthritistreatment recommendations
Figures from the paper
Abstract (AI)
Guidelines and recommendations developed and/or endorsed by the American College of Rheumatology (ACR) are intended to provide guidance for particular patterns of practice and not to dictate the care of a particular patient.The ACR considers adherence to these guidelines and recommendations to be voluntary, with the ultimate determination regarding their application to be made by the physician in light of each patient's individual circumstances.Guidelines and recommendations are intended to promote beneficial or desirable outcomes but cannot guarantee any specific outcome.Guidelines and recommendations developed or endorsed by the ACR are subject to periodic revision as warranted by the evolution of medical knowledge, technology, and practice.
Key Findings
1
Application of the recommendations is voluntary and should be determined by physicians according to each patient’s circumstances.
2
The 2012 ACR update revises the 2008 recommendations for using disease-modifying antirheumatic drugs and biologic agents to treat rheumatoid arthritis.
3
The guidelines are subject to periodic revision as medical knowledge, technology, and clinical practice evolve.
4
The recommendations aim to promote beneficial outcomes but cannot guarantee any specific clinical outcome.
5
The recommendations provide guidance for particular treatment patterns but are not intended to dictate care for individual patients.
Research Object
Disease-modifying antirheumatic drugs and biologic agents used in the treatment of rheumatoid arthritis
Research Subject
Recommendations and guidance for the use of these therapies in rheumatoid arthritis treatment
Publication Details
Publication Date
2012-04-02
Journal
Publisher
ISSN
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest